Food, Drugs, and Cosmetics - Gene Structure- and Function-Modifying Products - Labeling

This bill requires manufacturers and sellers in Maryland to label products made using modern biotechnology (like gene editing or RNA interference) that alter gene structure or function. Such products must display the phrase "Gene Structure- or Function-Modifying Product" prominently, along with information about potential effects on users or others who may contact them. Businesses violating this rule face misdemeanor charges, fines up to $25,000 for repeat offenses, or civil penalties of $5,000 per violation. The law, effective October 1, 2026, directly affects companies selling these biotech products within Maryland.